Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeUp to 65
SponsorIlsan Cha hospital
About this trial
This single-center study at CHA Ilsan Medical Center compares intraoperative hemodynamics between remimazolam- and propofol-based total intravenous anesthesia (TIVA) in patients undergoing robot-assisted gynecologic surgery requiring pneumoperitoneum and steep Trendelenburg positioning.
Eligibility criteria
Qualifiers
Female patients <65 years of age
American Society of Anesthesiologists (ASA) physical status I-II
Scheduled to undergo robotic hysterectomy under general anesthesia
Disqualifiers
Body mass index (BMI) > 35 kg/m²
Baseline hypotension (systolic blood pressure <100 mmHg) or bradycardia (heart rate <60 bpm)
History of ischemic heart disease or cardiac conduction block
Significant cardiopulmonary disease, including hypoxemia (SpO₂ <90%), uncontrolled asthma, or chronic obstructive pulmonary disease (COPD)
Trial design
Treatments tested in this trial
- Remimazolam
- Propofol
Treatment groups
58 Participants
are divided into 2 treatment groupsLocations
2CHA Ilsan Medical Center10414, Goyang-siGyeonggi-do, South Korea
CHA Ilsan Medical Center Goyang-si South Korea
Sponsors and collaborators
Ilsan Cha hospital
Lead sponsor
Source ClinicalTrials.gov